A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
NCT00092872
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
359
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
MK0557
Sponsor
Merck Sharp & Dohme LLC